A detailed history of 626 Financial, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, 626 Financial, LLC holds 2,333 shares of ABT stock, worth $267,735. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,333
Previous 2,333 -0.0%
Holding current value
$267,735
Previous $242,000 9.5%
% of portfolio
0.15%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$109.52 - $120.96 $10,952 - $12,096
100 Added 4.48%
2,333 $265,000
Q4 2023

Jan 11, 2024

SELL
$90.19 - $110.4 $18,038 - $22,080
-200 Reduced 8.22%
2,233 $245,000
Q3 2023

Oct 11, 2023

SELL
$95.53 - $114.62 $9,553 - $11,462
-100 Reduced 3.95%
2,433 $235,000
Q1 2021

Apr 14, 2022

BUY
$108.84 - $128.23 $275,691 - $324,806
2,533 New
2,533 $300,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track 626 Financial, LLC Portfolio

Follow 626 Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 626 Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 626 Financial, LLC with notifications on news.